A Hiatus That Widens Quietly After the Sleeve

A 329-patient endoscopic cohort found a new hiatal hernia in 14.3% of sleeve patients one year after surgery, and it roughly tripled the odds of reflux esophagitis — while barely moving what patients reported.

sleeve gastrectomycomplicationslong-term outcomesbariatric surgery

At a bariatric unit in Buenos Aires, 329 patients had a sleeve gastrectomy with an intact hiatus at the start. One year later, 47 of them — 14.3% — had a hiatal hernia. Esophagitis appeared in 32.6% of those patients against 14.1% of the ones whose hiatus stayed closed; adjusted for preoperative esophagitis and symptoms, age, BMI, weight loss and sex, the hernia carried an odds ratio of 3.22 (95% CI 1.58–6.55) for mucosal injury.

What it did not do was make people complain. New reflux symptoms were more frequent in the hernia group, 30% against 16.1%, but the p value was 0.072 and the adjusted odds ratio 1.72 (0.80–3.69). Hernia size changed neither result.

The study, published in Obesity Surgery on 5 November, is a single-centre retrospective analysis of prospectively acquired data. It cannot say whether the sleeve creates the hernia or uncovers one already forming, and a year is a short window. Its value is the protocol: endoscopy before the operation and again a year after, in everyone, symptomatic or not.

Closing the gap at the first operation

Seven weeks earlier, a group in Bergamo published the interventional version of the same question. Four hundred consecutive patients had a sleeve in 2019, and a hiatal hernia was identified during the operation in 115 of them — 28.8%, far above the Buenos Aires figure, because it counts what a surgeon can palpate on the day rather than what an endoscope documents later. Seventy-five were repaired with a posterior cruroplasty; 40 were left alone.

Five-year endoscopy was available for 356 patients, 89.0% of the cohort. Esophagitis was present in 36 of them, 10.1%, almost all low grade: 27 Los Angeles class A, nine class B, none C or D. Barrett’s esophagus turned up in four patients, 1.1%, and 24.7% were still taking a proton pump inhibitor. Esophagitis appeared in 5.3% of the repaired hernias (4 of 75), 22.5% of the unrepaired ones (9 of 40) and 9.5% of patients who never had a hernia (23 of 241), an overall p of 0.013. Against leaving the hernia in place, repair carried an odds ratio of 0.19 (0.06–0.68), which a stratified estimate moved to 0.14 (0.04–0.57). No Barrett’s esophagus appeared in anyone who had a repair.

Read that as a cohort study, not a trial: the decision to repair belonged to the surgeon, so the 40 unrepaired patients are the ones judged not worth repairing — exactly where other explanations for reflux tend to live. The repaired group even beat patients who never had a hernia, which is more plausibly selection than evidence that cruroplasty protects beyond normal anatomy. What survives is the contrast inside the hernia group: 22.5% against 5.3% at five years is a gap an endoscopy programme can see.

The exit is no longer automatic

For most of the last decade the answer to reflux after a sleeve was conversion to a gastric bypass. A Cleveland group has now published an algorithm that treats it as one of four options. Sixty-four patients with persistent reflux after sleeve, operated between 2015 and 2021, went through esophagram, manometry, Bravo pH testing and endoscopy first. Forty-one were converted, 26 with a hiatal repair; 19 received magnetic sphincter augmentation, 12 with a repair; three had repair alone and one radiofrequency ablation. GERD-HRQL scores fell from 38.9 to 9.3, high-dose daily proton pump inhibitor use from 95% to 64%, and 28% were off the drugs at long-term follow-up. Outcomes did not differ by procedure (p = 0.455 and 0.817), and 36% avoided conversion. Those converted had a mean BMI of 41.4 against 32.5, the honest clue to how the choice was made.

The only randomized comparison in the stack

Eighty patients with obesity and mild-to-moderate reflux were randomized in Xinjiang to a sleeve with a fundoplication (27) or a standard sleeve (53). The wrap was tailored during the operation to sphincter pressure — Dor at 180 degrees, Toupet at 270, Nissen at 360 — and weight loss came out equivalent. Reflux symptoms and healed esophagitis favoured the wrapped group at six and twelve months. Two limits matter: an allocation lopsided enough that the abstract does not explain it, and follow-up that stops at a year, where the Bergamo data begin.

What the three papers cannot settle

None of them can say how often the operation leaves a hernia behind, because none share a denominator. One counted hernias that appeared at a fixed endoscopic check, one counted hernias a surgeon felt and chose to fix, one counted them in patients ill enough with reflux to be worked up for a second operation. We have followed reflux before as the variable that decides which operation a patient gets; after the sleeve it decides something narrower — whether an esophagus is being injured while its owner feels fine. No registry field records hiatal status or repair at the time of a sleeve, which is why the LABS cohort, funded by NIDDK and documented in this archive, remains the template for the follow-up that would settle it.

The asymmetry is worth stating plainly: a program that scopes only the patients who report heartburn will find the hernias that hurt, and miss the ones that do not.

This archive is independent of NIH and NIDDK and reports published research only; nothing here is medical advice.

Sources

  1. Is postoperative hiatal hernia an issue after sleeve gastrectomy? (Obesity Surgery, 5 November 2026)
  2. Concomitant hiatal hernia repair during laparoscopic sleeve gastrectomy and 5-year endoscopic esophagitis: a retrospective cohort study of 400 patients (Surgical Endoscopy, 16 September 2026)
  3. A tailored approach for reflux management after sleeve gastrectomy: dispelling the notion that all need conversion to a gastric bypass (Surgery for Obesity and Related Diseases, 29 July 2026)
  4. Comparative efficacy of sleeve gastrectomy with fundoplication versus standard sleeve gastrectomy in obesity and gastroesophageal reflux disease: a randomised trial (Diabetes, Obesity and Metabolism, December 2025)
From the blog

New research notes